Strategic Adaptation in the Diabetes Healthcare Sector

This chapter explores how a company with 30 U.S. sites has rapidly adjusted its production to meet demands in the diabetes medication market, showcasing its operational scale of 500 million products. It ends with a lively lightning round, engaging listeners on diverse investment questions.